Cargando…
Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study
BACKGROUND AND PURPOSE: The intestinal microbiome plays a primary role in the pathogenesis of neurodegenerative disorders and may provide an opportunity for disease modification. We performed a pilot clinical study looking at the safety of fecal microbiota transplantation (FMT), its effect on the mi...
Autores principales: | DuPont, Herbert L., Suescun, Jessika, Jiang, Zhi-Dong, Brown, Eric L., Essigmann, Heather T., Alexander, Ashley S., DuPont, Andrew W., Iqbal, Tehseen, Utay, Netanya S., Newmark, Michael, Schiess, Mya C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019775/ https://www.ncbi.nlm.nih.gov/pubmed/36937520 http://dx.doi.org/10.3389/fneur.2023.1104759 |
Ejemplares similares
-
IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes
por: Brown, Eric L., et al.
Publicado: (2023) -
A Study of the Relationship Between Uric Acid and Substantia Nigra Brain Connectivity in Patients With REM Sleep Behavior Disorder and Parkinson's Disease
por: Ellmore, Timothy M., et al.
Publicado: (2020) -
2517. Oral Fecal Microbiota Transplantation Increases Gut Microbiome Diversity and Alters the Microbiome Distribution in People with HIV
por: Utay, Netanya S, et al.
Publicado: (2019) -
Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation
por: DuPont, Herbert L., et al.
Publicado: (2022) -
Evaluation of Six Weekly Oral Fecal Microbiota Transplants in People with HIV
por: Utay, Netanya S., et al.
Publicado: (2020)